BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
You have strategic business objectives. We have the network and expertise to help you realize your goals. We assemble a team that works closely with you to develop a customized investment solution.
Together, we can design a tailored investment approach to support corporate or family office initiatives, market expansion objectives, business development strategies, or any other focused business goals you have in mind.
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.